These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


313 related items for PubMed ID: 8611425

  • 1. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
    Maelandsmo GM, Flørenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Børresen AL, Fodstad O.
    Br J Cancer; 1996 Apr; 73(8):909-16. PubMed ID: 8611425
    [Abstract] [Full Text] [Related]

  • 2. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J.
    Cancer Res; 1996 Dec 01; 56(23):5475-83. PubMed ID: 8968104
    [Abstract] [Full Text] [Related]

  • 3. Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
    Maelandsmo GM, Berner JM, Flørenes VA, Forus A, Hovig E, Fodstad O, Myklebost O.
    Br J Cancer; 1995 Aug 01; 72(2):393-8. PubMed ID: 7640224
    [Abstract] [Full Text] [Related]

  • 4. p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression.
    Piccinin S, Doglioni C, Maestro R, Vukosavljevic T, Gasparotto D, D'Orazi C, Boiocchi M.
    Int J Cancer; 1997 Feb 20; 74(1):26-30. PubMed ID: 9036865
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system.
    Wang Y, Becker D.
    Oncogene; 1996 Mar 07; 12(5):1069-75. PubMed ID: 8649798
    [Abstract] [Full Text] [Related]

  • 6. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H.
    Cancer Res; 1997 Oct 15; 57(20):4608-14. PubMed ID: 9377576
    [Abstract] [Full Text] [Related]

  • 7. Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas.
    Simpson DJ, Frost SJ, Bicknell JE, Broome JC, McNicol AM, Clayton RN, Farrell WE.
    Carcinogenesis; 2001 Aug 15; 22(8):1149-54. PubMed ID: 11470742
    [Abstract] [Full Text] [Related]

  • 8. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features.
    Semczuk A, Miturski R, Skomra D, Jakowicki JA.
    Arch Gynecol Obstet; 2004 Jan 15; 269(2):104-10. PubMed ID: 14648178
    [Abstract] [Full Text] [Related]

  • 9. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 10. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
    Burns KL, Ueki K, Jhung SL, Koh J, Louis DN.
    J Neuropathol Exp Neurol; 1998 Feb 01; 57(2):122-30. PubMed ID: 9600204
    [Abstract] [Full Text] [Related]

  • 11. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J.
    Mol Cell Biol; 1995 May 01; 15(5):2600-11. PubMed ID: 7739541
    [Abstract] [Full Text] [Related]

  • 12. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
    Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL, Sanchez-Beato M, Soler F, Perez-Losada A, Nayach I, Mallofré C, Piris MA, Montserrat E, Cardesa A.
    Am J Pathol; 1996 May 01; 148(5):1591-600. PubMed ID: 8623927
    [Abstract] [Full Text] [Related]

  • 13. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
    Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B, Windhager R, Gadner H.
    Oncogene; 1997 Oct 01; 15(18):2225-32. PubMed ID: 9393981
    [Abstract] [Full Text] [Related]

  • 14. Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas.
    Bachmann IM, Straume O, Akslen LA.
    Int J Oncol; 2004 Dec 01; 25(6):1559-65. PubMed ID: 15547691
    [Abstract] [Full Text] [Related]

  • 15. Mutation analysis of the pRb pathway in 2',3'-dideoxycytidine- and 1, 3-butadiene-induced mouse lymphomas.
    Zhuang SM, Wiseman RW, Söderkvist P.
    Cancer Lett; 2000 May 01; 152(2):129-34. PubMed ID: 10773403
    [Abstract] [Full Text] [Related]

  • 16. Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma.
    Asp J, Inerot S, Block JA, Lindahl A.
    J Orthop Res; 2001 Jan 01; 19(1):149-54. PubMed ID: 11332612
    [Abstract] [Full Text] [Related]

  • 17. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK, Medina D.
    Mol Carcinog; 1998 Jun 01; 22(2):128-43. PubMed ID: 9655257
    [Abstract] [Full Text] [Related]

  • 18. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN.
    J Neuropathol Exp Neurol; 1996 Oct 01; 55(10):1026-31. PubMed ID: 8857999
    [Abstract] [Full Text] [Related]

  • 19. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
    Nielsen GP, Burns KL, Rosenberg AE, Louis DN.
    Am J Pathol; 1998 Jul 01; 153(1):159-63. PubMed ID: 9665476
    [Abstract] [Full Text] [Related]

  • 20. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
    Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J.
    Nature; 1995 Jun 08; 375(6531):503-6. PubMed ID: 7777060
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.